SCHEMBL1877973

SCHEMBL1877973

NNC(=O)c1ccsc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL8856781 0.83 HPGD (0.50)
SCHEMBL28078669 0.82 HDAC1 (0.72)
SCHEMBL12181209 0.80
SCHEMBL5160725 0.79 CES2 (0.54)
SCHEMBL18912328 0.79 HDAC1 (0.56)
SCHEMBL15296676 0.79 HDAC1 (0.56)
SCHEMBL3415908 0.78
SCHEMBL6957032 0.78
SCHEMBL7223253 0.78 HDAC1 (0.60)
SCHEMBL8627533 0.78 HDAC1 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8099973-A None JP disclosed
EP-4168399-B1 COMPOUNDS AND THEIR USES AS MIF INHIBITORS NANJING IMMUNOPHAGE BIOMEDICAL CO LTD (CN) 2026-04-01 EP disclosed
CN-114989155-B 1,3, 4-oxadiazole thioether derivative, and preparation method and application thereof 河北农业大学 2024-04-02 CN disclosed
US-20240083912-A1 COMPOUNDS AND THEIR USES AS MIF INHIBITORS NANJING IMMUNOPHAGE BIOTECH CO LTD (CN) 2024-03-14 US disclosed
US-11884682-B2 Compounds and their uses as MIF inhibitors Nanjing Immunophage Biotech Co., Ltd. (CN) 2024-01-30 US disclosed
CN-116438174-A Compounds and their use as MIF inhibitors 南京艾美斐生物医药科技有限公司 2023-07-14 CN disclosed
EP-4168399-A1 COMPOUNDS AND THEIR USES AS MIF INHIBITORS Nanjing Immunophage Biotech Co., Ltd. (CN) 2023-04-26 EP disclosed
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
CN-114989155-A 1,3, 4-oxadiazole thioether derivative and preparation method and application thereof 河北农业大学 2022-09-02 CN disclosed
US-20030060467-A1 Pyrazolo-triazine derivatives as ligands for gaba receptors MERCK SHARP & DOHME LTD. (GB) 2003-03-27 US disclosed
EP-1282623-A1 PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP &amp; DOHME LTD. (GB) 2003-02-12 EP disclosed
WO-2001077111-A1 PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2001-10-18 WO disclosed
US-20010026915-A1 Colorimetric glycopolythiophene biosensors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-10-04 US disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed
JP-H0899973-A THIOPHENE MONOMER HAVING DIACYLHYDRAZIDE GROUP ON SIDE CHAIN MITSUBISHI PAPER MILLS LTD 1996-04-16 JP disclosed
EP-0566446-A1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020046-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR PREPARATION OF SAME AND THEIR USE AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed
US-4111956-A Process for the manufacture of heterocyclic compounds IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1978-09-05 US disclosed